标题
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 5, Issue 7, Pages e1310-e1310
出版商
Springer Nature
发表日期
2014-07-03
DOI
10.1038/cddis.2014.269
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer
- (2015) Colin D. Weekes et al. NEOPLASIA
- An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease
- (2013) Merlin Nanayakkara et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Small Molecule Inhibitors of CXCR4
- (2013) Bikash Debnath et al. Theranostics
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Sequential therapy in metastatic renal cell carcinoma: pre-clinical and clinical rationale for selecting a second- or subsequent-line therapy with a different mechanism of action
- (2012) José Luís González Larriba et al. CANCER AND METASTASIS REVIEWS
- mTOR inhibitors in cancer therapy
- (2012) Yekaterina Y. Zaytseva et al. CANCER LETTERS
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
- (2012) Guang Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells
- (2012) K E Luker et al. ONCOGENE
- CXCR7 impact on CXCL12 biology and disease
- (2012) Lorena Sánchez-Martín et al. TRENDS IN MOLECULAR MEDICINE
- Treatment of everolimus-resistant metastatic renal cell carcinoma with VEGF-targeted therapies
- (2011) V Grünwald et al. BRITISH JOURNAL OF CANCER
- CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration
- (2011) Fabien M. Décaillot et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
- (2011) M P Rettig et al. LEUKEMIA
- Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness
- (2011) Juan Antonio Sánchez-Alcañiz et al. NEURON
- CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration
- (2011) Yanling Wang et al. NEURON
- Involvement of mTOR in CXCL12 Mediated T Cell Signaling and Migration
- (2011) Rachel Munk et al. PLoS One
- Mechanisms of mTOR inhibitor resistance in cancer therapy
- (2011) Jennifer S. Carew et al. Targeted Oncology
- The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects
- (2010) K. Hattermann et al. CANCER RESEARCH
- Overlapping and distinct role of CXCR7-SDF-1/ITAC and CXCR4-SDF-1 axes in regulating metastatic behavior of human rhabdomyosarcomas
- (2010) Katarzyna Grymula et al. INTERNATIONAL JOURNAL OF CANCER
- Chemokine receptor CXCR7 regulates the invasion,angiogenesis and tumor growth of human hepatocellular carcinoma cells
- (2010) Ke Zheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Alterations in VHL as potential biomarkers in renal-cell carcinoma
- (2010) Lucy Gossage et al. Nature Reviews Clinical Oncology
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
- (2010) Ulrike Naumann et al. PLoS One
- Dissecting the role of mTOR: Lessons from mTOR inhibitors
- (2009) Ryan J.O. Dowling et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
- (2009) M. Gupta et al. BLOOD
- CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
- (2009) A. Levoye et al. BLOOD
- Elucidation of CXCR7-Mediated Signaling Events and Inhibition of CXCR4-Mediated Tumor Cell Transendothelial Migration by CXCR7 Ligands
- (2009) B. A. Zabel et al. JOURNAL OF IMMUNOLOGY
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
- (2009) I. Kalatskaya et al. MOLECULAR PHARMACOLOGY
- -arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7
- (2009) S. Rajagopal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells
- (2008) Isaya Hashimoto et al. EUROPEAN JOURNAL OF CANCER
- Chemokines as therapeutic targets in renal cell carcinoma
- (2008) Karen L Reckamp et al. Expert Review of Anticancer Therapy
- Essential but differential role for CXCR4 and CXCR7 in the therapeutic homingof human renal progenitor cells
- (2008) Benedetta Mazzinghi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
- (2008) J A Burger et al. LEUKEMIA
- CXCR7 transcription in human non-small cell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy
- (2008) Torsten Goldmann et al. VIRCHOWS ARCHIV
- Strong Expression of Chemokine ReceptorCXCR4 by Renal Cell Carcinoma Correlates with Advanced Disease
- (2008) Thomas C. Wehler et al. Journal of Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started